XML 117 R8.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 6 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Jan. 01, 2024
Net cash used in operating activities      
Net Income $ 243.7 $ 431.6  
Adjustments to reconcile net income to net cash used in operating activities:      
Stock-based compensation 119.9 132.0  
Amortization of deferred sales commissions 39.0 28.3  
Impairment of intangible assets 24.4 0.0  
Depreciation and other amortization 60.7 57.5  
Amortization of intangible assets 225.1 170.4  
Net losses (gains) on investments 10.3 (41.6)  
Income from investments in equity method investees (15.5) (81.3)  
Net losses (gains) on investments of consolidated investment products 101.8 (3.0)  
Net purchase of investments by consolidated investment products (230.7) (232.2)  
Deferred income taxes (39.9) (15.0)  
Other 139.2 57.4  
Changes in operating assets and liabilities:      
Increase in receivables and other assets (48.2) (55.1)  
Decrease in investments, net 3.3 10.0  
Decrease in accrued compensation and benefits (488.0) (316.0)  
Decrease in income taxes payable (266.3) (177.2)  
Increase (decrease) in accounts payable, accrued expenses and other liabilities (33.8) 22.6  
Decrease in accounts payable and accrued expenses of consolidated investment products (40.3) (103.7)  
Net cash used in operating activities (195.3) (115.3)  
Net cash used in investing activities      
Purchase of investments (545.1) (501.0)  
Liquidation of investments 480.2 543.6  
Purchase of investments by consolidated collateralized loan obligations (3,199.4) (2,294.3)  
Liquidation of investments by consolidated collateralized loan obligations 2,357.1 1,769.9  
Additions of property and equipment, net (109.3) (61.2)  
Acquisitions, net of cash acquired (including $281.4 in cash and cash equivalents of consolidated investment products in fiscal year 2024) 0.0 (177.9)  
Payments of deferred consideration liability 0.0 (60.8)  
Net (deconsolidation) consolidation of investment products (4.1) 15.1  
Net cash used in investing activities (1,020.6) (410.8)  
Net cash provided by financing activities      
Issuance of common stock 10.2 7.3  
Dividends paid on common stock (339.4) (321.4)  
Repurchase of common stock (15.8) (70.5)  
Proceeds from debt 300.0 0.0  
Payment on debt (400.0) 0.0  
Proceeds from repurchase agreement 41.2 0.0  
Payments on repurchase agreement (32.4) 0.0  
Proceeds from debt of consolidated investment products 3,266.5 587.4  
Payments on debt of consolidated investment products (2,596.9) (35.5)  
Payments on contingent consideration liabilities (0.7) (2.9)  
Noncontrolling interests 147.6 67.7  
Net cash provided by financing activities 380.3 232.1  
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations (34.2) 15.9  
Decrease in cash and cash equivalents (869.8) (278.1)  
Cash and cash equivalents, beginning of period 4,408.9 4,402.4  
Cash and Cash Equivalents, End of Period 3,539.1 4,124.3  
Supplemental Disclosure of Cash Flow Information      
Cash paid for income taxes 217.1 318.4  
Cash paid for interest 49.2 51.3  
Cash paid for interest by consolidated investment products $ 403.7 $ 345.6  
CIPs [Member] | Putnam Investments      
Cash and Cash Equivalents     $ 281.4